These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30793003)

  • 1. The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy.
    Matthews S; De Maria A; Passamonti M; Ristori G; Loiacono I; Puggina A; Curran D
    Open Forum Infect Dis; 2019 Feb; 6(2):ofz007. PubMed ID: 30793003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
    Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
    BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
    Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S
    Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Herpes Zoster and Postherpetic Neuralgia on the Quality of Life in China: A Prospective Study.
    Liu Y; Liu H; Bian Q; Zhang S; Guan Y
    Clin Cosmet Investig Dermatol; 2024; 17():1905-1915. PubMed ID: 39220293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.
    Mizukami A; Sato K; Adachi K; Matthews S; Holl K; Matsuki T; Kaise T; Curran D
    Clin Drug Investig; 2018 Jan; 38(1):29-37. PubMed ID: 29086340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
    Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
    J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.
    Coplan PM; Schmader K; Nikas A; Chan IS; Choo P; Levin MJ; Johnson G; Bauer M; Williams HM; Kaplan KM; Guess HA; Oxman MN
    J Pain; 2004 Aug; 5(6):344-56. PubMed ID: 15336639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
    Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
    Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged ≥50 years: A prospective study.
    Salvetti A; Ferrari V; Garofalo R; Gazzaniga P; Guerroni A; Metrucci A; Sessa A; Severi ML; Nati G; Ruggeri M; Rossi A; Cappellari L; Gopala K; Tosatto R; Simone B
    Prev Med Rep; 2019 Jun; 14():100882. PubMed ID: 31193254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
    Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
    BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study.
    Serpell M; Gater A; Carroll S; Abetz-Webb L; Mannan A; Johnson R
    Health Qual Life Outcomes; 2014 Jun; 12():92. PubMed ID: 24920439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B; Köster I; Reinhold T; Siedler A; Krause G; Icks A; Schubert I; Wichmann O
    Eur J Health Econ; 2013 Dec; 14(6):1015-26. PubMed ID: 23271349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV
    Eriksson J; Hunger M; Bourhis F; Thorén R; Popmihajlov Z; Finelli L; Jiang Y
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):613-621. PubMed ID: 31721601
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Miyun District of Beijing, China: An EQ-5D survey.
    Zhao D; Suo L; Lu L; Pan J; Peng X; Wang Y; Pang X
    Vaccine X; 2023 Dec; 15():100415. PubMed ID: 38124774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
    Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
    Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study.
    Tsai TF; Yao CA; Yu HS; Lan CC; Chao SC; Yang JH; Yang KC; Chen CY; White RR; Psaradellis E; Rampakakis E; Kawai K; Acosta CJ; Sampalis JS
    Int J Dermatol; 2015; 54(5):529-36. PubMed ID: 25209019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and economic burdens of postherpetic neuralgia in China.
    Yu SY; Fan BF; Yang F; DiBonaventura M; Chen YX; Li RY; King-Concialdi K; Kudel I; Hlavacek P; Hopps M; Udall M; Sadosky A; Cappelleri JC
    Clinicoecon Outcomes Res; 2019; 11():539-550. PubMed ID: 31564930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.
    Cebrián-Cuenca AM; Díez-Domingo J; San-Martín-Rodríguez M; Puig-Barberá J; Navarro-Pérez J;
    BMC Infect Dis; 2011 Nov; 11():302. PubMed ID: 22044665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.